跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
注射用盐酸苯达莫司汀 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Bendamustine Hydrochloride for Injection
Approved
化学药品
Bendamustine Hydrochloride for Injection
Sichuan Huiyu Pharmaceutical Co., Ltd.
🇨🇳 National Medical Products Administration
Approval Date
Feb 24, 2021
Approval ID
84MkVfVhTmi
Company
Sichuan Huiyu Pharmaceutical Co., Ltd.
Type
化学药品
Approval Details
Approval Id
84MkVfVhTmi
Approval Number
国药准字H20213144
Generic Name
注射用盐酸苯达莫司汀
Generic Name En
Bendamustine Hydrochloride for Injection
Drug Type
化学药品
Dosage Form
注射剂
Strength
按C16H21Cl2N3O2·HCl计 100mg
Reg Date
2021-02-24
Company Name
Sichuan Huiyu Pharmaceutical Co., Ltd.
Company Address
四川省内江市市中区汉阳路333号3幢
Production Company Name
Sichuan Huiyu Pharmaceutical Co., Ltd.
Production Company Address
四川省内江市市中区汉阳路333号3幢
Company Detail Path
/organization/sichuan-huiyu-pharmaceutical-co-ltd
Production Company Detail Path
/organization/sichuan-huiyu-pharmaceutical-co-ltd
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Feb 24, 2021
Approval ID
84MkVfVhTmi
Type
化学药品
Back to NMPA Approvals